G&S Capital’s Elanco Animal Health ELAN Stock Holding History

G&S Capital’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-63	Closed	-$1K	–	99
2020 Q1	$1K	Hold	63	–	–	﹤0.01%	179
2019 Q4	$1K	Hold	63	–	–	﹤0.01%	210
2019 Q3	$2K	Hold	63	–	–	﹤0.01%	203
2019 Q2	$2K	Hold	63	–	–	﹤0.01%	214
2019 Q1	$2K	Hold	63	–	–	﹤0.01%	203
2018 Q4	$2K	Buy	+63	New	+$2.06K	﹤0.01%	199

Other funds holding ELAN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

G&S Capital's ELAN Position: Q2 2020 in Review

G&S Capital sold out of Elanco Animal Health (ELAN) in Q2 2020, closing a stake of 63 shares — an estimated $1K sold.

G&S Capital first reported a position in ELAN in Q4 2018 and held it in 6 quarters. The position peaked at $2K in Q3 2019. 372 funds tracked by Wall St. Rank hold ELAN as of Q2 2020.

G&S Capital reported no remaining Elanco Animal Health position as of Q2 2020 after selling out during the quarter.
G&S Capital sold 63 Elanco Animal Health shares in Q2 2020, an estimated $1K.
G&S Capital first reported a position in Elanco Animal Health in Q4 2018 and held it in 6 quarters.
G&S Capital's Elanco Animal Health position peaked at $2K in Q3 2019.
372 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2020.

Based on G&S Capital's 13F filing for Q2 2020, filed 24 Jul 2020.